China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999:
SAYS Q3 NET PROFIT DOWN 4.3% Y/Y
China Resources Sanjiu Medical & Pharmaceutical Q3 Net Profit Down 4.3% Y/Y
Earlier from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A
- China Resources Sanjiu Medical & Pharma To Invest In Wealth Management Products
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 4.99% but net profit down 24.31% as Tasly acquisition reshapes business
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue and profit declined, but asset growth and Tasly integration drive future potential
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue and net profit surged on strong CHC and prescription drug growth, with a 50% payout